The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

JAK Inhibitors Could Reverse Immunotherapy-Induced Diabetes

Immunotherapy-induced sort 1 diabetes is a severe aspect impact confronted by some sufferers receiving therapy for most cancers.Nonetheless, a group of researchers from...

What Can Affect Immunotherapy Responses in Kidney Most cancers?

Throughout a presentation on the 2025 Kidney Most cancers Analysis Summit, Dr. Berkay Simsek, a analysis fellow in pathology at Brigham and Girls’s...

Affected person Perspective: Adversarial Occasions and Tolerability

Quickly after prognosis, remedy started shortly, with the primary infusion taking place on a birthday. Regardless of the emotional weight of that day...

Rising from Isolation After Most cancers Reaped Many Rewards

Ron Cooper acquired a prognosis of prostate most cancers in 2014 and is at present in energetic surveillance. Compensate for all of Ron's blogs...

Guiding Sufferers With Metastatic Breast Most cancers on Therapy Selections

Dr. Masey Ross helps sufferers with metastatic breast most cancers perceive their therapy choices.At a current CURE Educated Affected person® Updates occasion, sufferers...

Hot Topics